Revolution Medicines executive sells shares under trading plan
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Revolution Medicines commercialization chief Anthony Mancini sold 811 shares for Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context